112 related articles for article (PubMed ID: 12121653)
41. Structural features of the interleukin-10 family of cytokines.
Zdanov A
Curr Pharm Des; 2004; 10(31):3873-84. PubMed ID: 15579076
[TBL] [Abstract][Full Text] [Related]
42. An antibody loop replacement design feasibility study and a loop-swapped dimer structure.
Clark LA; Boriack-Sjodin PA; Day E; Eldredge J; Fitch C; Jarpe M; Miller S; Li Y; Simon K; van Vlijmen HW
Protein Eng Des Sel; 2009 Feb; 22(2):93-101. PubMed ID: 19074157
[TBL] [Abstract][Full Text] [Related]
43. Neutralizing epitopes on the extracellular interferon gamma receptor (IFNgammaR) alpha-chain characterized by homolog scanning mutagenesis and X-ray crystal structure of the A6 fab-IFNgammaR1-108 complex.
Sogabe S; Stuart F; Henke C; Bridges A; Williams G; Birch A; Winkler FK; Robinson JA
J Mol Biol; 1997 Nov; 273(4):882-97. PubMed ID: 9367779
[TBL] [Abstract][Full Text] [Related]
44. Recurring conformation of the human immunodeficiency virus type 1 gp120 V3 loop.
Stanfield RL; Ghiara JB; Ollmann Saphire E; Profy AT; Wilson IA
Virology; 2003 Oct; 315(1):159-73. PubMed ID: 14592768
[TBL] [Abstract][Full Text] [Related]
45. Interleukin-10 receptor-1 expression in monocyte-derived antigen-presenting cell populations: dendritic cells partially escape from IL-10's inhibitory mechanisms.
von Haehling S; Wolk K; Höflich C; Kunz S; Grünberg BH; Döcke WD; Reineke U; Asadullah K; Sterry W; Volk HD; Sabat R
Genes Immun; 2015; 16(1):8-14. PubMed ID: 25472783
[TBL] [Abstract][Full Text] [Related]
46. 1.9 A crystal structure of interleukin 6: implications for a novel mode of receptor dimerization and signaling.
Somers W; Stahl M; Seehra JS
EMBO J; 1997 Mar; 16(5):989-97. PubMed ID: 9118960
[TBL] [Abstract][Full Text] [Related]
47. A complex of influenza hemagglutinin with a neutralizing antibody that binds outside the virus receptor binding site.
Fleury D; Barrère B; Bizebard T; Daniels RS; Skehel JJ; Knossow M
Nat Struct Biol; 1999 Jun; 6(6):530-4. PubMed ID: 10360354
[TBL] [Abstract][Full Text] [Related]
48. Crystal structure of the principal neutralization site of HIV-1.
Ghiara JB; Stura EA; Stanfield RL; Profy AT; Wilson IA
Science; 1994 Apr; 264(5155):82-5. PubMed ID: 7511253
[TBL] [Abstract][Full Text] [Related]
49. Structure of a Potential Therapeutic Antibody Bound to Interleukin-16 (IL-16): MECHANISTIC INSIGHTS AND NEW THERAPEUTIC OPPORTUNITIES.
Hall G; Cullen E; Sawmynaden K; Arnold J; Fox S; Cowan R; Muskett FW; Matthews D; Merritt A; Kettleborough C; Cruikshank W; Taylor D; Bayliss R; Carr MD
J Biol Chem; 2016 Aug; 291(32):16840-8. PubMed ID: 27231345
[TBL] [Abstract][Full Text] [Related]
50. Structure and mechanism of receptor sharing by the IL-10R2 common chain.
Yoon SI; Jones BC; Logsdon NJ; Harris BD; Deshpande A; Radaeva S; Halloran BA; Gao B; Walter MR
Structure; 2010 May; 18(5):638-48. PubMed ID: 20462497
[TBL] [Abstract][Full Text] [Related]
51. Local and transmitted conformational changes on complexation of an anti-sweetener Fab.
Guddat LW; Shan L; Anchin JM; Linthicum DS; Edmundson AB
J Mol Biol; 1994 Feb; 236(1):247-74. PubMed ID: 7893280
[TBL] [Abstract][Full Text] [Related]
52. Receptor-binding conformation of the "ELR" motif of IL-8: X-ray structure of the L5C/H33C variant at 2.35 A resolution.
Gerber N; Lowman H; Artis DR; Eigenbrot C
Proteins; 2000 Mar; 38(4):361-7. PubMed ID: 10707023
[TBL] [Abstract][Full Text] [Related]
53. Structural Mimicry of Receptor Interaction by Antagonistic Interleukin-6 (IL-6) Antibodies.
Blanchetot C; De Jonge N; Desmyter A; Ongenae N; Hofman E; Klarenbeek A; Sadi A; Hultberg A; Kretz-Rommel A; Spinelli S; Loris R; Cambillau C; de Haard H
J Biol Chem; 2016 Jun; 291(26):13846-54. PubMed ID: 27129274
[TBL] [Abstract][Full Text] [Related]
54. Induced pocket to accommodate the cell attachment Arg-Gly-Asp motif in a neutralizing antibody against foot-and-mouth-disease virus.
Verdaguer N; Mateu MG; Bravo J; Domingo E; Fita I
J Mol Biol; 1996 Feb; 256(2):364-76. PubMed ID: 8594203
[TBL] [Abstract][Full Text] [Related]
55. [Spatial structure of a Fab-fragment of a monoclonal antibody to human interleukin-2 in two crystalline forms at a resolution of 2.2 and 2.9 angstroms].
Fokin AV; Afonin PV; Mikhaĭlova IIu; Tsygannik IN; Mareeva TIu; Nesmeianov VA; Pangborn W; Lee N; Duax W; Siszak E; Pletnev VZ
Bioorg Khim; 2000 Aug; 26(8):571-8. PubMed ID: 11040993
[TBL] [Abstract][Full Text] [Related]
56. Anchoring a cationic ligand: the structure of the Fab fragment of the anti-morphine antibody 9B1 and its complex with morphine.
Pozharski E; Wilson MA; Hewagama A; Shanafelt AB; Petsko G; Ringe D
J Mol Biol; 2004 Mar; 337(3):691-7. PubMed ID: 15019787
[TBL] [Abstract][Full Text] [Related]
57. Three-dimensional structures of the free and antigen-bound Fab from monoclonal antilysozyme antibody HyHEL-63(,).
Li Y; Li H; Smith-Gill SJ; Mariuzza RA
Biochemistry; 2000 May; 39(21):6296-309. PubMed ID: 10828942
[TBL] [Abstract][Full Text] [Related]
58. Exome sequencing identifies novel compound heterozygous mutations of IL-10 receptor 1 in neonatal-onset Crohn's disease.
Mao H; Yang W; Lee PP; Ho MH; Yang J; Zeng S; Chong CY; Lee TL; Tu W; Lau YL
Genes Immun; 2012 Jul; 13(5):437-42. PubMed ID: 22476154
[TBL] [Abstract][Full Text] [Related]
59. A polar ring endows improved specificity to an antibody fragment.
Schaefer ZP; Bailey LJ; Kossiakoff AA
Protein Sci; 2016 Jul; 25(7):1290-8. PubMed ID: 27334407
[TBL] [Abstract][Full Text] [Related]
60. Structure and humanization of a rat monoclonal Fab to human interleukin-5.
Cook WJ; Walter LJ; Murgolo NJ; Chou CC; Petro M; Zavodny PJ; Narula SK; Ramanathan L; Trotta PP; Nagabhushan TL
Protein Eng; 1996 Jul; 9(7):623-8. PubMed ID: 8844835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
